Plasmalemmal vacuolar H+-ATPase is decreased in microvascular endothelial cells from a diabetic model

Journal of Cellular Physiology

Volumn 201, Issue 2, 2004, Pages 190-200

  Rojas, Jose D ^a   Sennoune, Souad R ^a   Martinez, Gloria M ^a   Bakunts, Karina ^a   Meininger, Cynthia J ^b   Wu, Guoyao ^c   Wesson, Donald E ^a   Seftor, Elisabeth A ^d   Hendrix, Mary J C ^d   Martínez Zaguilán, Raul ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM ION;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PH; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; RAT;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CYTOPLASM; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED BB; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 4644256731     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20059     Document Type: Article

References (41)

1. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A. 1999. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239-2242.
2. Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H, Ruther W, Hansen-Algenstaedt N. 2003. Microvascular alterations in diabetic mice correlate with level of hyperglycemia. Diabetes 52:542-549.
3. Baatout S. 1997. Endothelial differentiation using Matrigel. Anticancer Res 17:451-455.
4. Beisswenger PJ, Spiro RJ. 1970. Human glomerular basement membrane: Chemical alteration in diabetes mellitus. Science 168: 596-598.
5. + independent and NEM sensitive. Am J Physiol (Cell Physiol) 257:C65-C76.
6. Bowman EJ, Siebers A, Altendorf K. 1988. Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plants. Proc Natl Acad Sci USA 85:7972-7976.
7. +)-ATPase in apical membranes from rat distal colon. J Biol Chem 274:19693-19698.
8. + antiport activity in bovine pulmonary artery endothelial cells. Am J Physiol 267:L649-L659.
9. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42:1184-1190.
10. Epstein M, Sowers JR. 1992. Diabetes mellitus and hypertension. Hypertension 19:403-418.
11. + exchange in human endothelial cells. Am J Physiol (Cell Physiol) 259:C640-C646.
12. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nature Med 1:27-31.
13. Gillies RJ, Martinez-Zaguilán R. 1991. Regulation of intracellular pH in BALB/c3T3 cells. J Biol Chem 266:1551-1556.
14. Gillies RJ, Martínez-Zaguilán R, Peterson EP, Perona R. 1992. Role of intracellular pH in mammalian cell proliferation. Cell Physiol Biochem 2:159-179.
15. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14-E22.
16. +-ATPase contains a filamentous actin binding site. J Biol Chem 275:32331-32337.
17. i in piglet cerebral microvascular endothelial cells: Recovery from an acid load. Proc Soc Exp Biol Med 212:256-262.
18. Jentsch TJ, Korbmacher C, Janicke I, Fischer DG, Stahl F, Helbig H, Hollwede H, Cragoe EJ, Keller SK, Wiederholt M. 1988. Regulation of cytoplasmic pH of cultured bovine corneal endothelial cells in the absence and presence of bicarbonate. J Membr Biol 103:29-40.
19. + exchange in erythrocytes of patients with NIDDM: A prospective study. Diabetologia 40:302-306.
20. +-ATPase and microfilaments during osteoclast activation. J Biol Chem 274:29164-29171.
21. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. 2003. Cellular dysfunction in the diabetic fibroblast: Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162:303-312.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
23. Lynch RM, Carrington W, Fogarty KE, Fay FS. 1996. Metabolic modulation of hexokinase association with mitochondria in living smooth muscle cells. Am J Physiol (Cell Physiol) 270:C488-C499.
24. 2+ using the fluorescence of SNARF-1 and Fura-2. Am J Physiol (Cell Physiol) 260:C297-C307.
25. +-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol (Cell Physiol) 265:C1015-C1029.
26. McCoy CL, McIntyre DJO, Robinson SP, Aboagye EO, Griffiths JR. 1996. Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation. Br J Cancer 74:s226-s231.
27. McMillan DE. 1997. Development of vascular complications in diabetes. Vasc Med 2:132-142.
28. Meininger CJ, Marinos RS, Hatakeyama K, Martinez-Zaguilan R, Rojas JD, Kelly KA, Wu G. 2000. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 349:353-356.
29. +-ATPase. J Biol Chem 265:5030-5036.
30. + exchange activity. Proc Natl Acad Sci USA 91:5898-5902.
31. Nanda A, Gukovskaya A, Tseng J, Grinstein S. 1992. Activation of vacuolar-type proton pumps by protein kinase C: Role in neutrophil pH regulation. J Biol Chem 267:22740-22746.
32. + antiport activity in diabetic nephropathy. Kidney Int 41:872-876.
33. +-ATPase-nature's most versatile proton pumps. Natl Rev Cell Mol Biol 3:94-103.
34. Putnam RW. 2001. Intracellular pH regulation. In: Speralakis N, editor. Cell physiology source book. 3rd edn. San Diego: Academic Press. pp 357-376.
35. Roos A, Boron WF. 1981. Intracellular pH. Physiol Rev 61:296-434.
36. + exchange in juvenile diabetes mellitus. J Hypertension 9:S222-S223.
37. Stehouwer C, Schaper NC. 1996. The pathogenesis of vascular complications of diabetes: One voice or many? Eur J Clin Invest 26:535-543.
38. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. 2002. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786.
39. Vaupel P. 1996. Is there a critical tissue oxygen tension for bioenergetic status and cellular pH regulation in solid tumors? Experentia 52:464-468.
40. Waltenberger J. 2001. Impaired collateral vessel development in diabetes: Potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49:554-560.
41. Ziegelstein RC, Cheng L, Capogrossi MC. 1992. Flow-dependent cytosolic acidification of vascular endothelial cells. Science 258: 656-658.